GE Healthcare

The product uses spin columns to extract high molecular weight DNA with an average length of 100 kb or more from animal and bacterial cells.

The cancer genetics testing provider acquired its new business unit from GE Healthcare.

NeoGenomics and GE Healthcare will also collaborate on a bioinformatics initiative for personalized oncology.

The deal gives Axiogenesis access to IP that will allow it to commercialize stem cell-derived assays and disease models for use in drug discovery.

The licenses provide non-exclusive access to the IP for research applications.